Enzymatic analysis of biomarkers for the monitoring of Gaucher patients in Colombia

Gene

Volumn 521, Issue 1, 2013, Pages 129-135

  Pacheco, Natalia ^a   Uribe, Alfredo ^a  

^a UNIVERSIDAD DE LOS ANDES   (Colombia)

Author keywords

Biomarkers; Dried blood spot; Gaucher disease

Indexed keywords

CHITOTRIOSIDASE; DIPEPTIDYL CARBOXYPEPTIDASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; COLOMBIA; COLORIMETRY; CONTROLLED STUDY; DRIED BLOOD SPOT TESTING; ENZYME ASSAY; ENZYME BLOOD LEVEL; FLUOROMETRY; GAUCHER DISEASE; HUMAN; PATIENT MONITORING; PRESCHOOL CHILD; PRIORITY JOURNAL; REFERENCE VALUE; SCHOOL CHILD; VALIDATION PROCESS;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COLOMBIA; DRIED BLOOD SPOT TESTING; FLUOROMETRY; GAUCHER DISEASE; HEXOSAMINIDASES; HUMANS; INFANT; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; REFERENCE VALUES; YOUNG ADULT;

EID: 84876707212     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.03.044     Document Type: Article

References (38)

1. Aerts J.M., Hollak C., Boot R., Groener A. Biochemistry of glycosphingolipid storage disorders: implications for therapeutic intervention. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2003, 358:905-914.
2. Aerts J.M.F.G., et al. Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodies. J. Inherit. Metab. Dis. 2011, 34:605-619.
3. Barone R., Simporé J., Malaguarnera L., Pignatelli S., Musumeci S. Plasma chitotriosidase activity in acute Plasmodium falciparum malaria. Clin. Chim. Acta 2003, 331:79-85.
4. Bodamer O.A., Hung C. Laboratory and genetic evaluation of Gaucher disease. Wien. Med. Wochenschr. 2010, 160:600-604.
5. Cabrera-Salazar M.a, O'Rourke E., Henderson N., Wessel H., Barranger J.a Correlation of surrogate markers of Gaucher disease: implications for long-term follow up of enzyme replacement therapy. Clin. Chim. Acta 2004, 344:101-107.
6. Campbell T.N., Choy F.Y.M. Gaucher disease and the synucleinopathies: refining the relationship. Orphanet J. Rare Dis. 2012, 7:12.
7. Chamoles N.A., Blanco M., Gaggioli D., Casentini C. Gaucher and Niemann-Pick diseases-enzymatic diagnosis in dried blood spots on filter paper: retrospective diagnoses in newborn-screening cards. Clin. Chim. Acta 2002, 317:191-197.
8. Coates D. The angiotensin converting enzyme (ACE). Int. J. Biochem. Cell Biol. 2003, 35:769-773.
9. Corti R., Sudano I., Binggeli C., Nava E., Noll G., Lüscher T.F. Endothelial dysfunction and regulation. Vascular Endothelium in Human Physiology and Pathophysiology 2000, 302. CRC Press, London. P.J. Vallance, D.J. Webb (Eds.).
10. Corvol P., Williams T.A., Soubrier F. Peptidyl dipeptidase A: angiotensin I-converting enzyme. Methods Enzymol. 1995, 248:283-305.
11. Cox T. Gaucher disease: understanding the molecular pathogenesis of sphingolipidoses. J. Inherit. Metab. Dis. 2001, 24:107-123.
12. Daitx V.V., Mezzalira J., Goldim M.P.D.S., Coelho J.C. Comparison between alpha-galactosidase A activity in blood samples collected on filter paper, leukocytes and plasma. Clin. Biochem. 2012, 45:1233-1238.
13. R Development Core Team R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing, ISBN 3-900 Available at. http://www.r-project.org.
14. Elleder M. Glucosylceramide transfer from lysosomes-the missing link in molecular pathology of glucosylceramidase deficiency: a hypothesis based on existing data. J. Inherit. Metab. Dis. 2006, 29:707-715.
15. Futerman A.H., van Meer G. The cell biology of lysosomal storage disorders. Nat. Rev. Mol. Cell Biol. 2004, 5:554-565.
16. Grabowski G.A. Phenotype, diagnosis, and treatment of Gaucher's disease. Lancet 2008, 372:1263-1271.
17. Grace M.E., Balwani M., Nazarenko I., Prakash-Cheng A., Desnick R.J. Type 1 Gaucher disease: null and hypomorphic novel chitotriosidase mutations-implications for diagnosis and therapeutic monitoring. Hum. Mutat. 2007, 28:866-873.
18. Hall A.J., Morroll S., Tighe P., Götz F., Falcone F.H. Human chitotriosidase is expressed in the eye and lacrimal gland and has an antimicrobial spectrum different from lysozyme. Microbes Infect. 2008, 10:69-78.
19. Harjanne A. Automated kinetic determination of angiotensin-converting enzyme in serum. Clin. Chem. 1984, 30:901-902.
20. HGNC Database, HUGO Gene Nomenclature Committee (HGNC), EMBL Outstation - Hinxton, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SD, UK. Jan, 2013. URL: http://www.genenames.org.
21. Hollak C.E., van Weely S., van Oers M.H., Aerts J.M. Marked elevation of plasma chitotriosidase activity: a novel hallmark of Gaucher disease. J. Clin. Invest. 1994, 93:1288-1292.
22. Jmoudiak M., Futerman A.H. Gaucher disease: pathological mechanisms and modern management. Br. J. Haematol. 2005, 129:178-188.
23. Kzhyshkowska J., Gratchev A., Goerdt S. Human chitinases and chitinase-like proteins as indicators for inflammation and cancer. Biomark. Insights 2007, 2:128-146.
24. Lambert D.W., Clarke N.E., Turner A.J. Not just angiotensinases: new roles for the angiotensin-converting enzymes. Cell Mol. Life Sci. 2010, 67:89-98.
25. Maire I., Guffon N., Froissart R. Current development and usefulness of biomarkers for Gaucher disease follow up. Rev. Med. Interne 2007, 28:S187.
26. Maire I., Guffon N., Piraud M., Froissart R. The role of current biomarkers in the management of lysosomal storage disorders. Clin. Ther. 2008, 30:S90-S91.
27. Malaguarnera L. Chitotriosidase: the yin and yang. Cell Mol. Life Sci. 2006, 63:3018-3029.
28. Matthew Morris, E., Fletcher, J. A, Thyfault, J.P., Scott Rector, R., in press. The role of angiotensin II in nonalcoholic steatohepatitis. Mol. Cell. Endocrinol. 1-12.
29. McDade T., Williams S., Snodgrass J. What a drop can do: dried blood spots as a minimally invasive method for integrating biomarkers into population-based research. Demography 2007, 44:899-925.
30. Michelin K., et al. Biochemical properties of beta-glucosidase in leukocytes from patients and obligated heterozygotes for Gaucher disease carriers. Clin. Chim. Acta 2005, 362:101-109.
31. Parkinson-Lawrence E.J., Shandala T., Prodoehl M., Plew R., Borlace G.N., Brooks D. Lysosomal storage disease: revealing lysosomal function and physiology. Physiology (Bethesda) 2010, 25:102-115.
32. Ronca-Testoni S. Direct spectrophotometric assay for angiotensin-converting enzyme in serum. Clin. Chem. 1983, 29:1093-1096.
33. Sumarac Z., et al. Biomarkers in Serbian patients with Gaucher disease. Clin. Biochem. 2011, 44:950-954.
34. Uribe A. Evaluation of chitotriosidase in dried blood spot collected of filter paper: reference values in control subjects and patients with lysosomal storage diseases. Rev. Investig. Clin. 2009, 61:23 - 23.
35. Uribe, A., Pacheco, N., submitted for publication. Chitotriosidase levels in dried blood spots: application of a microtechnique to the normal population and patients with lysosomal disorders. Clin. Biochem. 1-13.
36. Vellodi A. Lysosomal storage disorders. Br. J. Haematol. 2005, 128:413-431.
37. Vellodi A., Foo Y., Cole T.J. Evaluation of three biochemical markers in the monitoring of Gaucher disease. J. Inherit. Metab. Dis. 2005, 28:585-592.
38. Wajner A., et al. Biochemical characterization of chitotriosidase enzyme: comparison between normal individuals and patients with Gaucher and with Niemann-Pick diseases. Clin. Biochem. 2004, 37:893-897.